| 영문 | shigella | 한글 | 시겔라 |
|---|---|---|---|
| 설명 | 세균성 이질의 원인균. 창자내 세균과에 속하는 그람음성의 막대균이다. 협막, 편모가 없고 포도당을 분해하나 일부를 제외하고 가스를 생산치 않는다. 혈청형이나 생물학적 증상에 따라서 S. dysenteriae(A), S. flexneri(B), S. boydii(C), S. sonnei(D)의 4가지로 나뉜다. 경구감염으로 1~4일의 잠복기후에 발병한다. 발열, 복통, 점액혈변, 배가 무지근한 것이 주증상이다. 자연에서 사람과 원숭이에서만 병원성이 있으며, 기니픽에게 점안했을 경우의 각막염을 일으킨다. 병원성 발현에 필수한 상피세포침윤성을 플라스미드에 지배되며 시가독소의 존재도 알려져 있다. |
||
| Sh | sheep; Sherwood number; Shigella; shoulder |
|---|---|
| Shig | Shigella |
| SS | disulfide; sacrosciatic; saline soak; saline solution; saliva sample; saliva substitute; Salmonella-... |
| Ss | Shigella sonnei; subjects |
| SS | Salmonella--Shigella |
|---|
| Shigella | A gram-negative flagellated bacteria of the Eschericiae group, responsible for dysentery in humans. Infection by drinking contaminated water is common. (27 Sep 1997) |
|---|---|
| shigella boydii | One of the shigella species that produces bacillary dysentery (dysentery, bacillary). (12 Dec 1998) |
| shigella dysenteriae | A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that is extremely pathogenic and causes severe dysentery. Infection with this organism often leads to ulceration of the intestinal epithelium. (12 Dec 1998) |
| shigella flexneri | A bacterium which is one of the aetiologic agents of bacillary dysentery (dysentery, bacillary) and sometimes of infantile gastroenteritis. (12 Dec 1998) |
| shigella sonnei | A lactose-fermenting bacterium causing dysentery. (12 Dec 1998) |
| aids vaccines | Vaccines or candidate vaccines containing inactivated HIV or some of its component antigens and designed to prevent aids. Some vaccines containing antigens are recombinantly produced. (12 Dec 1998) |
| bacterial vaccines | Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease. (12 Dec 1998) |
| cancer vaccines | Vaccines or candidate vaccines designed to prevent or treat cancer. Vaccines are produced using the patient's own whole tumour cells as the source of antigens, or using tumour-specific antigens, often recombinantly produced. (12 Dec 1998) |
| vaccines | Vaccines are microbial preparations of killed or modified microorganisms which can stimulate an immune response in the body in order to prevent future infection with similar microorganism. The smallpox vaccine has totally eliminated the smallpox disease from our planet. (12 Dec 1998) |
| vaccines, attenuated | Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity. (12 Dec 1998) |
| vaccines, combined | Two or more vaccines in a single dosage form. (12 Dec 1998) |
| vaccines, conjugate | Semisynthetic vaccines consisting of polysaccharide antigens from microorganisms attached to protein carrier molecules. The carrier protein is recognised by macrophages and T-cells thus enhancing immunity. Conjugate vaccines induce antibody formation in people not responsive to polysaccharide alone, induce higher levels of antibody, and show a booster response on repeated injection. (12 Dec 1998) |
| vaccines, DNA | Recombinant DNA vectors encoding antigens administered for the prevention or treatment of disease. The host cells take up the DNA, express the antigen, and present it to the immune system in a manner similar to that which would occur during natural infection. This induces humoral and cellular immune responses against the encoded antigens. The vector is called naked DNA because there is no need for complex formulations or delivery agents; the plasmid is injected in saline or other buffers. (12 Dec 1998) |
| vaccines, inactivated | Vaccines in which the infectious microbial nucleic acid components have been destroyed by chemical or physical treatment (e.g., formalin, beta-propiolactone, gamma radiation) without affecting the antigenicity or immunogenicity of the viral coat or bacterial outer membrane proteins. (12 Dec 1998) |
| vaccines, synthetic | Small synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques. The latter vaccines may also be whole viruses whose nucleic acids have been modified. (12 Dec 1998) |
Synonyms : Vaccines, Shigella
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|